Frazier Healthcare Partners to Acquire MatrixCare From ResMed

ResMed Agrees to Sell MatrixCare to Frazier Healthcare Partners (Image Courtesy: pressfoto on Magnific)
ResMed Agrees to Sell MatrixCare to Frazier Healthcare Partners (Image Courtesy: pressfoto on Magnific)

Frazier Healthcare Partners (“Frazier”), a private equity firm focused exclusively on the healthcare industry, recently announced it has entered into a definitive agreement to acquire MatrixCare (the “Company”) from ResMed (NYSE & ASX: RMD).

MatrixCare is a leading provider of cloud-based EHR software purpose-built for out-of-hospital care settings, including skilled nursing, senior living, home health, hospice, and life plan communities. A multi-year winner of the Best in KLAS award, MatrixCare is trusted by thousands of facility-based and home-based care organizations to improve provider efficiencies and promote a better quality of life for the people they serve. The transaction includes MatrixCare and related software offerings historically sold under the MatrixCare brand, including Healthcare First, Citus, and home health and hospice solutions.

“Frazier has spent several years evaluating the post-acute care technology sector and believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living, and home health and hospice providers,” said Ryan Lucero, General Partner at Frazier Healthcare Partners. “We are thrilled to partner with the MatrixCare team and plan to invest aggressively in product innovation to help providers deliver better outcomes as the post-acute care landscape continues to evolve,” added Clarissa Berman, Principal at Frazier Healthcare Partners.

(Image Courtesy: Frazier Healthcare and MatrixCare official website)
(Image Courtesy: Frazier Healthcare and MatrixCare official website)

“This divestiture is aligned with Resmed’s 2030 strategy with a focused approach to portfolio management,” said Mick Farrell, Chairman and CEO of Resmed. “We’re confident that Frazier Healthcare is an excellent steward for our MatrixCare team members and solutions.”

The proposed transaction, which is subject to customary closing conditions, is expected to be completed during the third quarter of 2026.

Source

To learn more about partnerships between companies, click on the links below.

GENESIS Pharma Broadens Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics Across Nordic Markets

Origin Energy Partners With Landis+Gyr to Digitise Australian Gas Networks

Murata Partners with Synopsys to Support Ansys Electromagnetic and Thermal Analysis

RELATED ARTICLES

    Recent News